Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Anderson

Showing results (891-900 of 4,859) with videos related to

Pageof 486
Sort By:
Applied Research in Mental Retardation|January 1, 1981
Issues in mental retardation in Canada: transitionsG M Kysela, D Anderson, K Marfo
Journal of Medicinal Chemistry|July 11, 2006
Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecinsLin Song, Robert Bevins, Bradley D Anderson
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2006
Drug-drug interactions involving membrane transporters in the human kidneyMeng Li, Gail D Anderson, Joanne Wang
Neuropsychologia|August 12, 2006
The mnemonic mechanisms of errorless learningNicole D Anderson, Fergus I M Craik
Experimental Neurology|May 19, 2005
Quantitative assessment of forelimb motor function after cervical spinal cord injury in rats: relationship to the corticospinal tractKim D Anderson, Ardi Gunawan, Oswald Steward
Analytical Biochemistry|March 1, 1976
A quantitative method for the measurement of cellular guanosine triphosphate pool specific activitiesG Dolecki, D Anderson, L D Smith
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1992
Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidineD Feldman, C Brosnan, T D Anderson
Science (New York, N.Y.)|May 8, 1987
A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNAP X Guo, S Erickson, D Anderson
Medical Interface|November 4, 1995
The effect of health risk on medical costsD Anderson, S Brink, T D Courtney
Mutation Research|August 1, 1978
The potential carcinogenicity of methyl fluorosulphonate (CH3OSO2F;Magic Methyl)J Ashby, D Anderson, J A Styles
Pageof 486

Showing results (891-900 of 4,859) with videos related to

Sort By:
Pageof 486
Applied Research in Mental Retardation|January 1, 1981
Issues in mental retardation in Canada: transitionsG M Kysela, D Anderson, K Marfo
Journal of Medicinal Chemistry|July 11, 2006
Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecinsLin Song, Robert Bevins, Bradley D Anderson
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2006
Drug-drug interactions involving membrane transporters in the human kidneyMeng Li, Gail D Anderson, Joanne Wang
Neuropsychologia|August 12, 2006
The mnemonic mechanisms of errorless learningNicole D Anderson, Fergus I M Craik
Experimental Neurology|May 19, 2005
Quantitative assessment of forelimb motor function after cervical spinal cord injury in rats: relationship to the corticospinal tractKim D Anderson, Ardi Gunawan, Oswald Steward
Analytical Biochemistry|March 1, 1976
A quantitative method for the measurement of cellular guanosine triphosphate pool specific activitiesG Dolecki, D Anderson, L D Smith
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1992
Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidineD Feldman, C Brosnan, T D Anderson
Science (New York, N.Y.)|May 8, 1987
A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNAP X Guo, S Erickson, D Anderson
Medical Interface|November 4, 1995
The effect of health risk on medical costsD Anderson, S Brink, T D Courtney
Mutation Research|August 1, 1978
The potential carcinogenicity of methyl fluorosulphonate (CH3OSO2F;Magic Methyl)J Ashby, D Anderson, J A Styles
Pageof 486